Literature DB >> 9399540

Surveillance of cytomegalovirus after solid-organ transplantation: comparison of pp65 antigenemia assay with a quantitative DNA hybridization assay.

W Bossart1, K Bienz, W Wunderli.   

Abstract

In a multicenter study, 113 blood samples from 19 organ transplant patients were analyzed for cytomegalovirus by the pp65 antigenemia assay and a quantitative DNA hybridization assay. Overall, there was 84% agreement among the results obtained by the two tests. Fifteen of 16 episodes of active infection were detected by both assays. One episode was missed by the pp65 assay, and one patient showed significant DNA-emia but only low-level antigenemia.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9399540      PMCID： PMC230168          DOI： 10.1128/jcm.35.12.3303-3304.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction.

Authors:  T H The; M van der Ploeg; A P van den Berg; A M Vlieger; M van der Giessen; W J van Son
Journal:  Transplantation       Date:  1992-08       Impact factor: 4.939

2.  Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation.

Authors:  A P van den Berg; A M Tegzess; A Scholten-Sampson; J Schirm; M van der Giessen; T H The; W J van Son
Journal:  Transpl Int       Date:  1992-05       Impact factor: 3.782

Review 3.  The cytomegalovirus antigenemia assay: a plea for standardization.

Authors:  T H The; A P van den Berg; M C Harmsen; W van der Bij; W J van Son
Journal:  Scand J Infect Dis Suppl       Date:  1995

4.  Evaluation of the Digene Hybrid Capture System for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients.

Authors:  T Mazzulli; S Wood; R Chua; S Walmsley
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

5.  Cytomegalovirus preemptive therapy with ganciclovir in renal transplant patients treated with OKT3.

Authors:  E Gómez; M de Oña; S Aguado; F Tejada; M Nuñez; C Portal; C Diaz-Corte; E Sanchez; F Ortega; J Alvarez-Grande
Journal:  Nephron       Date:  1996       Impact factor: 2.847

6.  Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation.

Authors:  W J van Son; A P van den Berg; T H The; A M Tegzess
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

7.  Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients.

Authors:  J Niubò; J L Pérez; J T Martínez-Lacasa; A García; J Roca; J Fabregat; S Gil-Vernet; R Martín
Journal:  Diagn Microbiol Infect Dis       Date:  1996-01       Impact factor: 2.803

Review 8.  Prevention of cytomegalovirus disease.

Authors:  T C Bailey
Journal:  Semin Respir Infect       Date:  1993-09

9.  Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease.

Authors:  M L Landry; D Ferguson
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 10.  Current management of cytomegalovirus disease.

Authors:  P D Griffiths
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327
View more
  4 in total

1.  Evaluation of a leukocyte stabilization reagent for use in the cytomegalovirus pp65 antigenemia assay.

Authors:  C E Bush; J A Sluchak-Carlsen
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

2.  Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia.

Authors:  T Mazzulli; L W Drew; B Yen-Lieberman; D Jekic-McMullen; D J Kohn; C Isada; G Moussa; R Chua; S Walmsley
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  "pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies".

Authors:  Hajib N Madhavan; Moses Y Samson; Murali Ishwarya; Ramanathan Vijayakumar; Malathi Jambulingam
Journal:  Virol J       Date:  2010-11-16       Impact factor: 4.099

Review 4.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.